Physician profile
Mark A Trott
NPI 1205892924
$5,437.79
in general payments reported to CMS, 2019-2025
21 companies · $1,580 in 2025
The $1,580 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $538 · 2023: $1,480 · 2024: $1,728 · 2025: $1,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,589 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,588.81 |
| Education | $199.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,702.53 | 2021-2025 | Tremfya, Stelara, Remicade |
| Abbvie INC. | $1,557.96 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $554.18 | 2022-2025 | Sotyktu |
| Incyte Corporation | $402.28 | 2022-2025 | Opzelura |
| Genzyme Corporation | $193.01 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $174.13 | 2023-2025 | Dupixent |
| Leo Pharma INC. | $147.96 | 2022-2023 | Adbry |
| Pfizer INC. | $130.43 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $102.79 | 2023-2025 | Absorica Ld, Winlevi, Blu-U |
| Novartis Pharmaceuticals Corporation | $76.00 | 2024-2025 | |
| Galderma Laboratories, L.P. | $73.14 | 2024-2025 | Aklief, Nemluvio, Oracea |
| Dermavant Sciences, INC. | $64.19 | 2023-2024 | Vtama |
| Amgen INC. | $54.00 | 2023-2024 | Otezla |
| Organon LLC | $39.04 | 2024-2025 | Vtama |
| Ucb, INC. | $35.77 | 2024 | Bimzelx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $24.98 | 2024 | |
| Lilly USA, LLC | $24.75 | 2023 | Olumiant, Taltz |
| Verrica Pharmaceuticals INC. | $21.45 | 2024 | Ycanth |
| Ani Pharmaceuticals, INC. | $21.25 | 2024 | Purified Cortrophin Gel |
| Biofrontera INC. | $19.71 | 2022 | |
| Arcutis Biotherapeutics, INC. | $18.24 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Trott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.